Company Filing History:
Years Active: 2023
Title: Innovator Spotlight: Tim Chan and His Contributions to Cancer Therapy
Introduction: Tim Chan is an innovative inventor based in Frederick, MD, who has made significant strides in the field of cancer therapy. As a key member of Precigen, Inc., he focuses on developing cutting-edge technologies to combat devastating diseases such as acute myeloid leukemia (AML). His research and inventions have the potential to transform treatment efficacy and patient outcomes in the oncology space.
Latest Patents: Tim Chan holds a patent for CD33 specific chimeric antigen receptors. This groundbreaking invention provides chimeric antigen receptors (CARs) specifically designed for cancer therapy, incorporating a single-chain variable fragment (scFv) derived from a CD33 monoclonal antibody. These CARs are engineered to target and destroy cancerous cells, particularly in cases of proliferative disorders like AML and relapsed or refractory AML.
Career Highlights: Tim Chan's career has been marked by his dedication to advancing cancer treatment through innovative approaches. His role at Precigen, Inc. allows him to collaborate with other experts in the field, focusing on pragmatic solutions that can be translated into real-world applications for patients. The impact of his work is evident in the ongoing research and clinical applications stemming from his inventions.
Collaborations: Throughout his career, Tim has collaborated with notable colleagues, including Rutul R Shah and Peter Emtage. Working alongside these talented individuals has further propelled his research, fostering an environment of innovation and shared expertise aimed at improving cancer therapies.
Conclusion: Tim Chan exemplifies the spirit of innovation in the field of cancer therapy, with his patent on CD33 specific chimeric antigen receptors representing a vital advancement in the fight against leukemia. His contributions at Precigen, Inc. and collaborations with esteemed coworkers highlight his commitment to pushing the boundaries of medical science. As he continues to develop new avenues for treatment, the future of cancer therapy looks promising.